ArticleAnnals of surgical oncology2025
Association Between Surgery and Death from Cardiovascular Disease Among Patients with Laryngeal Cancer: A Large Population-Based Cohort Study.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the association between surgical treatment of laryngeal cancer and cardiovascular disease (CVD) mortality, comparing CVD mortality risk between surgery and no-surgery groups.
methodsWe extracted patients with laryngeal cancer from the Surveillance, Epidemiology, and End Results database and conducted an evaluation of these patients. Patients and study characteristics were taken into account when conducting subgroup analyses.
resultsA total of 38,600 laryngeal cancer patients were included in our study, among whom 22,547 died and 3373 died specifically from CVDs. Notably, we found that within specific subgroups, such as individuals aged ≥40 years; both sexes; patients diagnosed between 2005 and 2019; Black or White patients; those with tumors in the supraglottis, subglottis, and not otherwise specified; grade I and II tumors; localized and distant stages; and regardless of chemotherapy or radiation therapy, surgery use was associated with a lower CVD mortality risk. This finding was consistent across various marital statuses and income levels.
conclusionsNo-surgery management correlated with significantly elevated CVD mortality risk compared with surgery treatment.
Indexed as
Identifiers
40987983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.